Optimising experimental research in respiratory diseases: an ERS statement

Philippe Bonniaud, Aurelie Fabre, Nelly Frossard, Christophe Guignabert, Mark Inman, Wolfgang M. Kuebler, Tania Maes, Wei Shi, Martin Stampfli, Stefan Uhlig, Eric White, Martin Witzenrath, Pierre-Simon Bellaye, Bruno Crestani, Oliver Eickelberg, Heinz Fehrenbach, Andreas Guenther, Gisli Jenkins, Guy Joos, Antoine MagnanBernard Maitre, Ulrich A. Maus, Petra Reinhold, Juanita H. J. Vernooy, Luca Richeldi, Martin Kolb

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number1702133
Number of pages34
JournalEuropean Respiratory Journal
Volume51
Issue number5
DOIs
Publication statusPublished - 1 May 2018

Keywords

  • IDIOPATHIC PULMONARY-FIBROSIS
  • ACUTE LUNG INJURY
  • COMMUNITY-ACQUIRED PNEUMONIA
  • CIGARETTE-SMOKE EXPOSURE
  • INBRED MOUSE STRAINS
  • ALLERGIC AIRWAY INFLAMMATION
  • HIGHLAND WHITE TERRIERS
  • ANIMAL-MODELS
  • DISTRESS-SYNDROME
  • ARTERIAL-HYPERTENSION

Cite this

Bonniaud, P., Fabre, A., Frossard, N., Guignabert, C., Inman, M., Kuebler, W. M., Maes, T., Shi, W., Stampfli, M., Uhlig, S., White, E., Witzenrath, M., Bellaye, P-S., Crestani, B., Eickelberg, O., Fehrenbach, H., Guenther, A., Jenkins, G., Joos, G., ... Kolb, M. (2018). Optimising experimental research in respiratory diseases: an ERS statement. European Respiratory Journal, 51(5), [1702133]. https://doi.org/10.1183/13993003.02133-2017